Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery
D. Alexiou et al., Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery, EUR J CANC, 37(18), 2001, pp. 2392-2397
The serum concentrations oft he cell adhesion molecules E-select in, interc
ellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1
(VCAM-1) were investigated in 63 patients with colorectal cancer and in 51
controls by an enzyme-linked immunosorbent assay (ELISA). Their relationshi
p to clinicopathological variables and patient survival and changes in thei
r levels after surgery were examined. Colorectal cancer patients showed sig
nificantly higher serum levels of E-selectin, ICAM-1 and VCAM-1 compared wi
th healthy controls. There was a significant association between. the serum
levels of these molecules, disease stage and the presence of both lymph no
de and distant metastases. Both ICAM-1 and VCAM-1 levels correlated with se
rum E-selectin and carcinoembryonic antigen (CEA) levels. Serum levels of a
ll three molecules decreased significantly after radical resection of the t
umour. Elevated pre-operative E-selectin. ICAM-1 and VCAM-1 levels were sig
nificant prognostic factors, although not independent of stage. for patient
survival. These findings suggest that serum concentrations of E-selectin,
ICAM-1 and VCAM-1 may reflect tumour progression and metastasis. Since thes
e markers are linked to CEA levels, it is uncertain whether their measureme
nt will prove cost-effective in colorectal cancer management. (C) 2001 Else
vier Science Ltd. All rights reserved.